Heartbeam

Heartbeam ROA

The Return on Assets (ROA) of Heartbeam (BEAT) as of Oct 24, 2026 is -359.66 %. In the previous year, Return on Assets (ROA) was -593.65 % — a change of -39.42% (higher).

ROA

-359.66 %

YoY

-39.42%

Last updated:

In 2025, Heartbeam's return on assets (ROA) was -359.66 %, a -39.42% increase from the -593.65 % ROA in the previous year.

The Heartbeam ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
7.30 USD
Jan 1, 2019
-11,114.29 USD
Jan 1, 2020
-2,643.14 USD
Jan 1, 2021
-31.63 USD
Jan 1, 2022
-317.58 USD
Jan 1, 2023
-85.45 USD
Jan 1, 2024
-593.65 USD
Jan 1, 2025
-359.66 USD
The Heartbeam ROA history
YEARROAYoY
-359.66 %-39.42%
-593.65 %+594.71%
-85.45 %-73.09%
-317.58 %+903.94%
-31.63 %-98.80%
-2,643.14 %-76.22%
-11,114.29 %-152,409.06%
7.30 %-339.90%
-3.04 %-111.33%
26.85 %+348.82%
5.98 %-176.24%
-7.85 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Heartbeam Stock analysis

What does Heartbeam do? HeartBeam, Inc. generates revenue through its proprietary VECG technology platform, which includes two patented products: HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software designed for acute care settings, offering 3D comparison of baseline and symptomatic 12-lead ECG to detect heart attacks. HeartBeam AIMIGo is a credit card-sized 12-lead ECG device paired with a smartphone app and cloud-based diagnostic software for remote heart attack detection. The company targets healthcare facilities and remote monitoring segments, focusing on cardiovascular diagnostic solutions for both in-hospital and out-of-hospital settings. HeartBeam AIMI is sold to acute care providers such as hospitals and emergency departments, while HeartBeam AIMIGo serves patients and remote healthcare services seeking continuous cardiac monitoring. The firm's revenue streams derive from the commercialization of these two products, leveraging its patented VECG technology to provide higher resolution ambulatory ECG solutions. The company's focus on detecting and monitoring cardiac disease outside traditional healthcare facilities drives its product development and sales strategy. HeartBeam Inc. operates in the cardiovascular diagnostic technology sector, with its products designed to enable cardiac disease detection both inside and outside healthcare facilities. The firm's VECG platform allows for 3D vector imaging of cardiac electrical activity, enhancing diagnostic capabilities beyond standard ECG methods. Revenue is generated through the sale of software, devices, and cloud-based diagnostic systems tailored to specific healthcare environments and remote monitoring needs. Heartbeam is one of the most popular companies on Eulerpool.

ROA Details

Understanding Heartbeam's Return on Assets (ROA)

Heartbeam's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Heartbeam's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Heartbeam's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Heartbeam’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Heartbeam stock

Return on Assets (ROA) of Heartbeam is -359.66 % in 2025.

Return on Assets (ROA) of Heartbeam changed from -593.65 % to -359.66 %, representing a -39.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Heartbeam since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Heartbeam with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Heartbeam

All Key Metrics — Heartbeam